Epicrispr Biotechnologies vs Viridian Therapeutics, Inc.

Epicrispr Biotechnologies vs Viridian Therapeutics, Inc., compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Viridian Therapeutics, Inc. on 43/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.
Try Viridian Therapeutics, Inc.

Where each one leads

Epicrispr Biotechnologies

  • our overall score: 62/100 against 43/100

Viridian Therapeutics, Inc.

  • funding raised: $350M against $90.0M

At a glance

MeasureEpicrispr BiotechnologiesViridian Therapeutics, Inc.
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, Pharmaceuticals, Healthcare, Life Sciences
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware | hardware | services | marketplace | platform
Founded20202017
HeadquartersSouth San Francisco, United StatesWaltham, United States
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesViridian Therapeutics, Inc.
Employees51Not published
Total funding$90.0M$350M
Latest roundSeries CPublic Offering
LinkedIn followers7,025Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesViridian Therapeutics, Inc.
StartupHub scoreOur 0-100 rating62/10043/100
Traction57/10040/100
Team40/10070/100
Search visibility20/10013/100
Quality78/10045/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (39/100)
Domain ratingLink authority, 0-10040/10042/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesViridian Therapeutics, Inc.
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJquery, Tailwind CSS, BootstrapJquery, Bootstrap
AnalyticsGoogle Analytics 4Google Tag Manager

Epicrispr Biotechnologies vs Viridian Therapeutics, Inc.: common questions

Which is better, Epicrispr Biotechnologies or Viridian Therapeutics, Inc.?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and Viridian Therapeutics, Inc. compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 43/100). Viridian Therapeutics, Inc. leads on funding raised ($350M against $90.0M).

Read the full Epicrispr Biotechnologies review and pricing or the Viridian Therapeutics, Inc. review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.